Endo Health Solutions | Endo International | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
Merck & Co. | Merck | consumer protection violation | 2012 | private lawsuit-state | $39,000,000 |
Wyeth Pharmaceuticals | Pfizer | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $39,000,000 |
Alere Inc. | Abbott Laboratories | False Claims Act and related | 2021 | DOJ_CIVIL | $38,750,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2024 | MD-AG | $38,166,450 |
Forest Laboratories and Forest Pharmaceuticals | AbbVie | False Claims Act and related | 2016 | DOJ_CIVIL | $38,000,000 |
Impax Laboratories, Inc. | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $37,500,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $37,500,000 |
Hoechst AG | Sanofi | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $37,000,000 |
InterMune Inc. | Roche | off-label or unapproved promotion of medical products | 2006 | FDA | $36,900,000 |
King Pharmaceuticals LLC | Pfizer | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $36,500,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $36,500,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
Organon USA Inc | Organon & Co. | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $36,000,000 |
Mallinckrodt LLC | Mallinckrodt | Controlled Substances Act violation | 2017 | DEA | $35,000,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | drug or medical equipment safety violation | 2017 | DOJ_CIVIL | $35,000,000 |
Pfizer | Pfizer | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $35,000,000 |
GlaxoSmithKline PLC | GSK plc | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $35,000,000 |
Medicis Pharmaceutical Corp. | Bausch Health | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $35,000,000 |
Momenta Pharmaceuticals Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $35,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2016 | private lawsuit-federal | $35,000,000 |
Pfizer Inc. et al. | Pfizer | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $35,000,000 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
Celgene Corporation | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $34,000,000 |
Genentech Inc. | Roche | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
ISTA Pharmaceuticals, Inc. | Bausch Health | False Claims Act and related | 2013 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
Watson, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
Alere Inc. | Abbott Laboratories | False Claims Act and related | 2018 | DOJ_CIVIL | $33,200,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2017 | MULTI-AG | $33,000,000 |
Genzyme Corporation | Sanofi | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $32,500,000 |
Organon | Organon & Co. | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $31,000,000 |
Schering-Plough | Merck | False Claims Act and related | 2008 | MO-AG | $31,000,000 |
Sandoz, Inc. | Sandoz Group | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
Mylan N.V. | Viatris | investor protection violation | 2019 | SEC | $30,000,000 |
Wyeth-Ayerst Laboratories Division | Pfizer | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
Allergan Inc. | AbbVie | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $30,000,000 |
Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
Indivior Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
Apotex Corp. | Apotex Corp. | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $30,000,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
Eli Lilly and Company | Eli Lilly | Foreign Corrupt Practices Act | 2012 | SEC | $29,398,734 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
Merck Sharp & Dohme Corp | Merck | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
GlaxoSmithKline | GSK plc | drug or medical equipment safety violation | 2009 | private lawsuit-federal | $28,000,000 |
Merck | Merck | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $27,700,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2014 | DOJ_CIVIL | $27,600,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Forest Laboratories LLC | AbbVie | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $27,200,000 |
Schering-Plough | Merck | False Claims Act and related | 2004 | DOJ_CIVIL | $27,000,000 |
Schering-Plough Corp. | Merck | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
St. Jude Medical Inc. | Abbott Laboratories | drug or medical equipment safety violation | 2021 | DOJ_CIVIL | $27,000,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Teva Parmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Boehringer Ingelheim Pharma GmbH | Boehringer Ingelheim | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
Pfizer Inc. | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $26,339,944 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Wyeth LLC | Pfizer | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $25,500,000 |
Sanofi | Sanofi | Foreign Corrupt Practices Act | 2018 | SEC | $25,200,000 |
Eli Lilly and Co. | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
McNeil-PPC Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2015 | FDA | $25,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | FDA | $25,000,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2016 | SEC | $25,000,000 |
Abbott Laboratories | Abbott Laboratories | off-label or unapproved promotion of medical products | 2018 | USAO | $25,000,000 |
Johnson & Johnson | Johnson & Johnson | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $25,000,000 |
Glenmark Pharmaceuticals Inc. | Glenmark Pharmaceuticals | False Claims Act and related | 2024 | DOJ_CIVIL | $25,000,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2013 | DOJ_CIVIL | $24,900,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2019 | DOJ_CIVIL | $24,750,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516 |
Biovail Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2009 | USAO | $24,647,876 |
Apotex Corp. | Apotex Corp. | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
Merck & Co., Inc. | Merck | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
Purdue Pharma | Purdue Pharma | drug or medical equipment safety violation | 2015 | KY-AG | $24,000,000 |
AbbVie Inc. | AbbVie | consumer protection violation | 2020 | CA-INS | $24,000,000 |
AstraZeneca | AstraZeneca | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $24,000,000 |
Pfizer, Inc. | Pfizer | False Claims Act and related | 2018 | DOJ_CIVIL | $23,850,000 |
Roussel Uclaf S.A. | Sanofi | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
Mylan Laboratories Inc. | Viatris | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Medicis Pharmaceutical Corp. | Bausch Health | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $23,000,000 |
Valeant Pharmaceuticals International, Inc. | Bausch Health | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $23,000,000 |
Merck, Sharp & Dohme Corp. | Merck | consumer protection violation | 2014 | private lawsuit-federal | $23,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | DOJ_CIVIL | $22,000,000 |
Biogen, Inc. | Biogen | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Eisai Company | Eisai | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |